RANKINGS

POPULAR STOCKS

ANGLE plc

LSE:AGL.L

Location

United Kingdom

Market Cap

USD 31.71 M

Share Price

USD 0.10

Avg Daily Volume

1,244,720

Change (1 day)

3.18%

Change (1 year)

-45.94%

Change (YTD)

-23.34%

ANGLE plc Price to Sales Ratio (P/S) on June 13, 2025: 11.40

ANGLE plc Price to Sales Ratio (P/S) is 11.40 on June 13, 2025, a -45.94% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • ANGLE plc 52-week low Price to Sales Ratio (P/S) is 23.88 on June 13, 2025, which is 109.43% above the current Price to Sales Ratio (P/S).
  • ANGLE plc 52-week low Price to Sales Ratio (P/S) is 10.84 on June 13, 2025, which is -4.89% below the current Price to Sales Ratio (P/S).
  • ANGLE plc average Price to Sales Ratio (P/S) for the last 52 weeks is 16.44.
Key data
Date Price to Sales Ratio (P/S) Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield
Market news
LSE: AGL.L

ANGLE plc

CEO Mr. Andrew David William Newland ACA, Meng
IPO Date March 17, 2004
Location United Kingdom
Headquarters Surrey Research Park
Employees 150
Sector 🏥 Health Care
Industries
Biotechnology
📊 Big Data
💻 Computers
🩺 Medical Instruments
💻 Telehealth
Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Similar companies

POLX.L

Polarean Imaging plc

USD 0.02

-4.42%

SCLP.L

Scancell Holdings plc

USD 0.13

-0.39%

AVCT.L

Avacta Group Plc

USD 0.46

-4.37%

StockViz Staff

June 16, 2025

Any question? Send us an email